D. citri genome

We present a systems-based pipeline approach for delivering commercial, grove-deployable solutions using a novel therapeutic delivery strategy and citrus transgenics. A data integration and analysis platform combining existing complex -omics/biological data with molecular/cellular research will steer hypothesis-driven testing of inhibitors of multiple molecular pathways to provide solutions that can be optimized by combinatorial delivery to citrus.
Research areas will include:
>Molecular interaction inhibitor discovery (gut membrane binding peptides, RNA aptamers and non-toxic chemical library screening) to block psyllid acquisition/ transmission of HLB and/or growth in the plant.
>dsRNA delivery to induce psyllid RNAi responses that block HLB transmission or kill the psyllid (or both).
>Optimization of a novel therapeutic delivery system that has negligible environmental impact, is economical in comparison to current control strategies and is highly adaptable for different solution strategies.